Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Cytek Biosciences, Inc.
| Metric | Cytek Biosciences, Inc. CTKBHealthcare |
|---|---|
| Quality Score | 60 / 100 |
| Revenue (latest) | $201M |
| Net income (latest) | −$67M |
| Operating margin | −20.0% |
| Net margin | −33.0% |
| Return on equity | −19.5% |
| Return on assets | −14.4% |
| Return on capital (ROCE) | −10.5% |
| Debt / equity | 0.35× |
| Revenue growth (YoY) | 0.5% |
| Altman Z″ (distress) | 6.15 |
| Accruals / assets | −13.4% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.